A new research report from UBS focuses on four top companies that are making great strides in treatments for patients -- and generating gigantic revenues.
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest report.
A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy for the rest of this year and 2015, and the analysts keep…
Jon OggStocks were firm yet again on Friday morning ahead of the PPI wholesale inflation report. Investors have been trying to decide where to put their money after the recent stock market…
Jon OggStocks were firm on Monday morning, looking to add to the recovery bounce from Friday. Investors have now been given an opportunity to look for stocks that have pulled back that…
In a new report from Oppenheimer, analysts combine their fundamental rating on a company of Outperform with positive earnings revisions, and then toss in a bullish technical profile for good measure.
ThinkstockA brand new research report from RBC highlights more than 50Â biotech event catalysts that are on the horizon. These are trial data, FDA decisions and company presentations coming soon. The analysts screened…
An new report from Credit Suisse highlights the stocks where large-cap fund managers have been placing new bets the most. We screened those stocks for ones rated Outperform at Credit Suisse.
bfishshadow via Wikimedia CommonsShort sellers shied away from four of the top five most shorted stocks on the Nasdaq between the June 30 and July 15 settlement dates. The outlier was Frontier…
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has now reported its second-quarter earnings. The largest biotech by market cap turned in earnings of $2.36 per share ($3.93 billion) on more than a 100% gain…
Jon C. Ogg ThinkstockEarnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will change during…
In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.
courtesy of Sirius XM RadioHere is a look at the seven Nasdaq-traded stocks with the largest number of shares held short as of June 30. Six of the seven experienced declines in…
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
A surge in short interest in Apple shares between the May 30 and June 13 settlement dates was enough to lift the tech giant into the top five most shorted stocks on…
